Nick Leschly, President and CEO at bluebird bio, Inc. (BLUE), sold 594 shares at $45.93 ($27K) on 2021-02-02, disclosed to the SEC on 2021-02-04.
Seasonal sale ($27k) by President and CEO — this insider has traded BLUE in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| TSVT | SELL | 2024-01-05 | $560K | — | Filing → |
| TSVT | SELL | 2023-08-24 | $102K | — | Filing → |
| TSVT | SELL | 2023-08-07 | $111K | — | Filing → |